-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.00-44.75% Downside
2seventy bio, Inc. Frequently Asked Questions
-
What analysts cover 2seventy bio, Inc.?
2seventy bio, Inc. has been rated by research analysts at Goldman Sachs in the past 90 days.